About FDA
Cumulative percentage of required workplace inspection completed within the FY
Cumulative FY 2010 Target: 100% of 530 inspections by 9/30/2010
Dictionary: RCRM employees perform periodic ESH surveys and audits to identify deficiencies and implement corrective procedures or abatement actions. RCRM also inspects and monitors building ventilation and exhaust systems, and makes recommendations, where necessary, to decrease the possibility of workplace air contamination. Additionally, RCRM inspects and provides recommendations for any other safety compliance issues.
Safety and Environmental Compliance inspections help to not only make the FDA employees safe, but also allow for research to be conducted in a safe environment.
Fiscal Year - 2010
Cumulative FY 2010 Target: 100% of 530 inspections by 9/30/2010
| Time | Target | Cumulative Percent |
|---|---|---|
| Oct 2009 | N/A | 15 |
| Nov 2009 | N/A | 21 |
| Dec 2009 | N/A | 35 |
| Jan 2010 | N/A | 39 |
| Feb 2010 | N/A | 43 |
| Mar 2010 | N/A | 58 |
| Apr 2010 | N/A | 62 |
| May 2010 | N/A | 65 |
| Jun 2010 | N/A | 74 |
| Jul 2010 | N/A | 82 |
| Aug 2010 | N/A | 89 |
| Sep 2010 | N/A | 110 |
FY 2010 Overall: 110%
Cumulative number of workplace inspections conducted within the FY
Fiscal Year - 2010
| Time | Cumulative Monthly Target | Cumulative Number |
|---|---|---|
| Oct 2009 | 44 | 81 |
| Nov 2009 | 88 | 110 |
| Dec 2009 | 132 | 188 |
| Jan 2010 | 176 | 206 |
| Feb 2010 | 220 | 229 |
| Mar 2010 | 264 | 308 |
| Apr 2010 | 308 | 330 |
| May 2010 | 352 | 347 |
| Jun 2010 | 396 | 390 |
| Jul 2010 | 440 | 437 |
| Aug 2010 | 484 | 470 |
| Sep 2010 | 528 | 583 |
FY 2010 Total: 583
Glossary
ESH
Environmental, Safety, and Health
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







